Amylyx Pharmaceuticals, Inc.

AMLX·NasdaqGS·Healthcare
Compare
29.40+0.20 (+0.68%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close29.20
Open30.65
Day range27.9030.50
52-week range10.8341.14
Off day high−3.61%
Off 52-week high−28.54%
Volume1.59M
Avg. volume (3M)2.15M
Market cap3.69B
EPS (TTM)-1.41
Forward P/E-26.96
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.08
Shares outstanding125.51M
Short interest13.22% of float
Earnings dateNov 5, 2026
Analyst target42.64
Profit margin0.00%

Against its peers

Compare in full ›
AMLX XERS NBIX AMRX ALKS 42C.SI
Market cap 3.69B 1.91B 16.81B 6.95B 7.71B 515.12M
P/E (TTM) — — 24.6 49.9 — —
Forward P/E -27.0 53.2 13.9 16.4 25.4 247.4
Price/book 13.7 -186.8 4.3 12.6 4.2 33.6
Dividend yield — — — — — —
1-year change +120.54% +4.86% +7.22% +72.88% +47.06% +259.26%
Today +0.68% +1.06% +0.73% −1.29% +0.44% −3.09%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
Biogen Inc.BIIB · Cambridge, MA 37.61B 254.46 +2.22%
Akamai Technologies, Inc.AKAM · Cambridge, MAOdds 12.35B 85.93 −0.69%
GE Vernova Inc.GEV · Cambridge, MA 220.43B 832.83 −9.30%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MAOdds 21.57B 161.08 +0.74%
HubSpot, Inc.HUBS · Cambridge, MA 11.09B 216.64 −4.21%
Nuvalent IncNUVL · Cambridge, MA 9.81B 123.96 0.00%
Scholar Rock Holding CorporationSRRK · Cambridge, MA 5.61B 46.09 +4.80%

The stocks whose daily moves over the past year went most closely with Amylyx Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT · Correlation 0.47 678.40M 12.28 +2.76%
Arcutis Biotherapeutics, Inc.ARQT · Correlation 0.40 4.28B 34.05 +6.41%
Relay Therapeutics, Inc.RLAY · Correlation 0.38 3.95B 18.03 +3.38%
Scholar Rock Holding CorporationSRRK · Correlation 0.38 5.61B 46.09 +4.80%
Beam Therapeutics Inc.BEAM · Correlation 0.38 2.88B 27.79 +5.55%
BioAge Labs, Inc.BIOA · Correlation 0.37 273.09M 5.95 −0.17%
Stoke Therapeutics, Inc.STOK · Correlation 0.37 1.78B 27.45 +1.70%
Acadia Pharmaceuticals Inc.ACAD · Correlation 0.35 3.70B 21.47 +4.38%

What visitors to Amylyx Pharmaceuticals's page also look at.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT 678.40M 12.28 +2.76%
Arcutis Biotherapeutics, Inc.ARQT 4.28B 34.05 +6.41%
Taysha Gene Therapies, Inc.TSHA 1.42B 4.3600 +6.60%
Edgewise Therapeutics, Inc.EWTX 4.08B 37.53 −0.40%
Stoke Therapeutics, Inc.STOK 1.78B 27.45 +1.70%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All AMLX news ›

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Mentioned with

Amylyx2Leerink Partners2Abcellera Biologics1American Diabetes Association1Amylin1Astrazeneca1Avalo Therapeutics1Barclays1

People in the coverage

Amylyx2Danessa Lincoln2Kim Johansen2Marketbeat2Michael Walen2Mitch Edgeman2

Themes

Earnings2EPS2Health2Healthcare2Ada1Analyst Recommendations1Biotech and Pharmaceuticals1Boost Price Target1

Most coverage from

  1. stocktitan.net1
  2. themarketsdaily.com1
  3. tradingview.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance